Phase II study of cetuximab in combination with carboplatin and docetaxel for patients with advanced/metastatic non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Belani, C. P.
Ramalingam, S.
Schreeder, M.
Steis, R.
Guidice, R.
Marshland, T.
Butler, B.
机构：
[1] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA
[2] Clearview Canc Inst, Huntsville, AL USA
[3] Atlanta Canc Care, Roswell, GA USA
[4] New Mexico Oncol Hematol Consultants, Albuquerque, NM USA
[5] Integrated Community Oncol Network, Orange Pk, FL USA
[6] Int Oncol Network, Baltimore, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7643
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Docetaxel (Taxotere®) and Carboplatin in the treatment of advanced non-small lung cancer (NSCLC)
    Schutte, W
    Bork, I
    Wollschlager, B
    Schadlich, S
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 90 - 90
  • [42] Cetuximab treatment in combination with gemcitabine/docetaxel or carboplatin/gemcitabine for chemonaive patients with advanced non-small cell lung cancer (NSCLC): Report on toxicity data from the ongoing Phase II/III GemTax IV study
    Pilz, L. R.
    Schmid-Bindert, G.
    Cicenas, S.
    Eschbach, C.
    Kollmeier, J.
    Kortsik, C.
    Schumann, C.
    Serke, M.
    Steins, M.
    Manegold, C.
    [J]. ONKOLOGIE, 2010, 33 : 9 - 10
  • [43] A phase II study of the docetaxel-ifosfamide-carboplatin combination in advanced non-small-cell lung cancer
    Kosmas, C
    Tsavaris, N
    Koutras, A
    Makatsoris, T
    Mylonakis, N
    Tzelepis, G
    Dimitrakopoulos, A
    Spyropoulos, K
    Polyzos, A
    Karabelis, A
    Kalofonos, HP
    [J]. ONCOLOGY, 2005, 69 (04) : 333 - 341
  • [44] Combination chemotherapy with carboplatin, docetaxel, and gemcitabine in advanced non-small-cell lung cancer: A phase II study
    Pectasides, D
    Aspropotamitis, A
    Halikia, A
    Visvikis, A
    Antoniou, F
    Kalantaridou, A
    Karvounis, N
    Batzios, S
    Athanassiou, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (12) : 3816 - 3821
  • [45] Biweekly docetaxel and carboplatin as first-line therapy in patients with advanced non-small cell lung cancer (NSCLC). Finally results of a phase II study
    Firvida, J. L.
    Esquerdo, G.
    Amenedo, M.
    Salgado, M.
    LLorca, C.
    Perez, E.
    Cervera Grau, J.
    Ramos, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [46] Phase I/II study of bortezomib in combination with carboplatin and bevacizumab as first line therapy in patients with advanced non-small cell lung cancer (NSCLC)
    Piperdi, Bilal
    Bradley, Kendra J.
    Bathini, Venu
    Zekos, Colleens M.
    Hanrahan-Boshes, Meredith
    Walsh, William V.
    [J]. CANCER RESEARCH, 2010, 70
  • [47] A phase II study of modulated-capecitabine and docetaxel in chemonaive patients with advanced non-small cell lung cancer (NSCLC)
    Bertino, Erin M.
    Bekaii-Saab, Tanios
    Fernandez, Soledad
    Diasio, Robert B.
    Karim, Nagla A.
    Otterson, Gregory A.
    Villalona-Calero, Miguel A.
    [J]. LUNG CANCER, 2013, 79 (01) : 27 - 32
  • [48] A multicenter phase II study of sorafenib in combination with erlotinib patients with advanced non-small cell lung cancer (NSCLC)
    Cho, B.
    Kim, S.
    Heo, D. S.
    Kang, S.
    Kim, H.
    Lee, D.
    Kim, D.
    Jung, M.
    Choi, J.
    Kim, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [49] Phase 2 study of bortezomib±docetaxel in advanced non-small cell lung cancer (NSCLC)
    Fanucchi, M
    Fossella, F
    Fidias, P
    Natale, R
    Belt, R
    Govindan, R
    Raez, L
    Schiller, J
    Kashala, O
    Kelly, K
    [J]. LUNG CANCER, 2005, 49 : S30 - S30
  • [50] Phase I study of docetaxel in combination with Gemcitabine as first line chemotherapy in patients with metastatic non-small cell lung cancer (NSCLC)
    Gatzemeier, U
    Bildat, S
    Harstrick, A
    Eberhardt, W
    Achterrath, W
    Krauss, C
    Wilke, HJ
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 93 - 93
12345